OSTEOEZE ONE-A-DAY

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

glucosamine sulfate sodium chloride, Quantity: 1.884 g (Equivalent: glucosamine sulfate, Qty 1.5 g); ascorbic acid, Quantity: 48.71 mg (Equivalent: ascorbic acid, Qty 45 mg); magnesium phosphate tribasic, Quantity: 210 mg (Equivalent: magnesium, Qty 42 mg)

Disponibbli minn:

Orion Laboratories Pty Ltd T/A Perrigo Australia

INN (Isem Internazzjonali):

Ascorbic acid,glucosamine sulfate sodium chloride,magnesium phosphate tribasic

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: magnesium stearate; povidone; hypromellose; tartaric acid; microcrystalline cellulose; titanium dioxide; macrogol 8000; glucose monohydrate; maltodextrin; carmellose sodium; lecithin

Rotta amministrattiva:

Oral

Indikazzjonijiet terapewtiċi:

Helps decrease/reduce/relieve cartilage loss/wear/tear/damage ; Aid/assist/helps connective tissue production/formation ; Decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis (Linked Indication:Decrease/reduce/relieve mild joint aches and pains; Helps maintain/supports healthy joint cartilage growth/development/production; Helps enhance/improve/promote joint mobility); Helps maintain/support joint cartilage health ; Helps enhance/promote healthy joint function ; Helps enhance/promote joint health ; Maintain/support joint health ; Maintain/support joint mobility/flexibility ; Decrease/reduce/relieve mild joint pain/soreness

Sommarju tal-prodott:

Visual Identification: ;

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2017-09-20